Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

9EXW

Crystal structure of the PWWP1 domain of NSD2 bound by compound 17.

This is a non-PDB format compatible entry.
Summary for 9EXW
Entry DOI10.2210/pdb9exw/pdb
DescriptorHistone-lysine N-methyltransferase NSD2, 1,2-ETHANEDIOL, 7-[3-methyl-5-[2-methyl-5-[(pyridin-3-ylamino)methyl]phenyl]imidazol-4-yl]-4~{H}-1,4-benzoxazin-3-one, ... (4 entities in total)
Functional Keywordsmethyl transferase, inhibitor, cancer drug discovery, transferase
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight39931.53
Authors
Collie, G.W. (deposition date: 2024-04-09, release date: 2024-05-29, Last modification date: 2024-06-19)
Primary citationCarlino, L.,Astles, P.C.,Ackroyd, B.,Ahmed, A.,Chan, C.,Collie, G.W.,Dale, I.L.,O'Donovan, D.H.,Fawcett, C.,di Fruscia, P.,Gohlke, A.,Guo, X.,Hao-Ru Hsu, J.,Kaplan, B.,Milbradt, A.G.,Northall, S.,Petrovic, D.,Rivers, E.L.,Underwood, E.,Webb, A.
Identification of Novel Potent NSD2-PWWP1 Ligands Using Structure-Based Design and Computational Approaches.
J.Med.Chem., 67:8962-8987, 2024
Cited by
PubMed Abstract: Dysregulation of histone methyl transferase nuclear receptor-binding SET domain 2 (NSD2) has been implicated in several hematological and solid malignancies. NSD2 is a large multidomain protein that carries histone writing and histone reading functions. To date, identifying inhibitors of the enzymatic activity of NSD2 has proven challenging in terms of potency and SET domain selectivity. Inhibition of the NSD2-PWWP1 domain using small molecules has been considered as an alternative approach to reduce NSD2-unregulated activity. In this article, we present novel computational chemistry approaches, encompassing free energy perturbation coupled to machine learning (FEP/ML) models as well as virtual screening (VS) activities, to identify high-affinity NSD2 PWWP1 binders. Through these activities, we have identified the most potent NSD2-PWWP1 binder reported so far in the literature: compound (pIC = 8.2). The compounds identified herein represent useful tools for studying the role of PWWP1 domains for inhibition of human NSD2.
PubMed: 38748070
DOI: 10.1021/acs.jmedchem.4c00215
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.43 Å)
Structure validation

226707

數據於2024-10-30公開中

PDB statisticsPDBj update infoContact PDBjnumon